8/12/2013 7:16:44 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Lupin, the country’s third largest pharmaceutical company, has just begun setting up a research and development (R&D) centre in the US, but the R&D head of Teva Pharmaceuticals and another top official from Sandoz, the generic pharmaceuticals division of global industry leader Novartis, are on board already. Lupin is identifying other key officials and expects to get the R&D centre operational around August next year. Vinita Gupta, CEO of Lupin, said the company started working on the US R&D project six months ago. “It’s a work in progress.
Help employers find you! Check out all the jobs and post your resume.
comments powered by